Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Data quality management in pharmacovigilance.

Marie Lindquist1

  • 1Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden. marie.lindquist@who-umc.org

Drug Safety
|September 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe.

Drug safety·2023
Same author

Risk and benefit issues are problems we all face.

The International journal of risk & safety in medicine·2022
Same author

Wiser after the event?

The International journal of risk & safety in medicine·2022
Same author

Future possibilities for The International Journal of Risk and Safety in Medicine.

The International journal of risk & safety in medicine·2021
Same author

What is fake news in science?

The International journal of risk & safety in medicine·2021
Same author

What is 'risk and safety in medicine'?

The International journal of risk & safety in medicine·2021
Same journal

Implementation Aspects of a Medicines Shortage Policy Tool: Evidence from Australia's Serious Scarcity Substitution Instruments.

Drug safety·2026
Same journal

Availability and Communication of Risk Management Strategies for Pregnancy Category X Medicines across Australian Medicine Information Sources.

Drug safety·2026
Same journal

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same journal

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Drug safety·2026
Same journal

Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan.

Drug safety·2026
Same journal

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis.

Drug safety·2026
See all related articles

Effective data quality management in pharmacovigilance enhances the utility of safety reports. This approach mitigates issues from incomplete data, improving patient safety outcomes.

Area of Science:

  • Pharmacovigilance
  • Pharmacoepidemiology
  • Data Science

Background:

  • Pharmacovigilance utilizes individual case safety reports and pharmacoepidemiological data.
  • Spontaneous reports have limitations, but data quality management can improve their usefulness.
  • Incomplete reports pose a significant challenge in pharmacovigilance.

Purpose of the Study:

  • To review quality dimensions within the initial pharmacovigilance data processing steps.
  • To provide examples of quality management in pharmacovigilance data.
  • To highlight the benefits of robust quality management systems.

Main Methods:

  • Describing quality dimensions in data collection, entry, storage, and maintenance.
  • Illustrating concepts with pharmacovigilance-specific examples.

Related Experiment Videos

  • Reviewing the components of quality management: planning, control, assurance, and improvement.

    • Main Results:

    • Quality dimensions are critical in the early stages of the data processing cycle.
    • Well-managed data quality reduces the impact of incomplete pharmacovigilance reports.
    • Transparent quality management systems are essential for data integrity.

    Conclusions:

    • Implementing comprehensive quality management systems is vital for pharmacovigilance.
    • Improved data quality benefits data handlers and ultimately patients.
    • Focusing on data quality enhances the reliability of safety information for decision-making.